Filing Details

Accession Number:
0001104659-21-099725
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-04 06:04:25
Reporting Period:
2021-08-03
Accepted Time:
2021-08-04 06:04:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1790340 Immuneering Corp IMRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1869953 Scott Barrett C/O Immuneering Corporation,
245 Main Street, Second Floor
Cambridge MA 02142
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-08-03 5,996 $0.00 5,996 No 4 C Direct
Class A Common Stock Acquisiton 2021-08-03 667 $15.00 6,663 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Series A Preferred Stock Disposition 2021-08-03 3,273 $0.00 3,273 $0.00
Class A Common Stock Series B Preferred Stock Disposition 2021-08-03 2,723 $0.00 2,723 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.